Gross Profit Analysis: Comparing Pharming Group N.V. and Lantheus Holdings, Inc.

Pharmaceutical Giants: A Decade of Gross Profit Growth

__timestampLantheus Holdings, Inc.Pharming Group N.V.
Wednesday, January 1, 201412551900021595165
Thursday, January 1, 20151355220006590427
Friday, January 1, 201613778000011768542
Sunday, January 1, 201716213500092587038
Monday, January 1, 2018174885000129203843
Tuesday, January 1, 2019174811000165412447
Wednesday, January 1, 2020138761000203056430
Friday, January 1, 2021187695000169670071
Saturday, January 1, 2022581703000188060000
Sunday, January 1, 2023709543000220104000
Loading chart...

Unleashing insights

Gross Profit Trends in the Pharmaceutical Sector

In the ever-evolving landscape of the pharmaceutical industry, understanding financial performance is crucial. This analysis delves into the gross profit trends of two prominent players: Pharming Group N.V. and Lantheus Holdings, Inc. Over the past decade, Lantheus Holdings has demonstrated a remarkable growth trajectory, with its gross profit surging by over 460% from 2014 to 2023. In contrast, Pharming Group N.V. has shown a steady increase, with a notable 920% rise in gross profit during the same period.

Key Insights

  • Lantheus Holdings, Inc. experienced a significant leap in 2022, with a 210% increase compared to the previous year.
  • Pharming Group N.V. saw its most substantial growth between 2016 and 2017, with an impressive 687% increase.

These trends highlight the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions can lead to substantial financial gains.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025